NEW YORK, Dec. 30, 2021 /PRNewswire/ --
If you own shares in any of the companies listed above and
would like to discuss our investigations or have any questions concerning
this notice or your rights or interests, please contact:
Joshua Rubin, Esq.
WeissLaw LLP
305 Broadway, 7th Floor
New York, NY 10007
(212) 682-3025
(888) 593-4771
[email protected]
Ortho Clinical Diagnostics Holdings plc (NASDAQ: OCDX)
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Ortho Clinical Diagnostics Holdings plc (NASDAQ: OCDX), in connection with the proposed acquisition of the company by Quidel Corporation ("Quidel"). Under the terms of the merger agreement, OCDX shareholders will receive $7.14 in cash and 0.1055 shares of common stock in the combined company for each OCDX common share that they own, representing implied per-share merger consideration of approximately $20.64 based upon Quidel's December 29, 2021 closing price of $128.00. If you own OCDX shares and wish to discuss this investigation or your rights, please call us or visit our website: https://www.weisslaw.co/news-and-cases/ocdx
Bottomline Technologies, Inc. (NASDAQ: EPAY)
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Bottomline Technologies, Inc. (NASDAQ: EPAY), in connection with the proposed acquisition of EPAY by Thoma Bravo. Under the terms of the merger agreement, EPAY's shareholders will receive $57.00 in cash for each share of EPAY common stock that they hold. If you own EPAY shares and wish to discuss this investigation or your rights, please call us or visit our website: https://www.weisslaw.co/news-and-cases/epay
MPB BHC, INC. (OTC: MPHX)
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of MPB BHC, INC. (OTC: MPHX), in connection with the proposed acquisition of the company by Alerus Financial Corporation ("Alerus"). Under the terms of the merger agreement, MPHX's shareholders will receive 0.74 of a share of Alerus for each MPHX share they own, representing implied per-share merger consideration of approximately $21.94 based upon Alerus's December 29, 2021 closing price of $29.65. If you own MPHX shares and wish to discuss this investigation or your rights, please call us or visit our website: https://www.weisslaw.co/news-and-cases/mphx
Casper Sleep Inc. (NYSE: CSPR)
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Casper Sleep Inc. (NYSE: CSPR) in connection with the proposed acquisition of the company by Durational Capital Management LP. Under the terms of the acquisition agreement, CSPR shareholders will receive $6.90 in cash for each share of CSPR common stock that they hold. If you own CSPR shares and wish to discuss this investigation or your rights, please call us or visit our website: https://www.weisslaw.co/news-and-cases/cspr
SOURCE WeissLaw LLP
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article